Department of Geriatrics, Xuanwu Hospital, Capital Medical University, China National Clinical Research Center for Geriatric Medicine, Beijing 100053, China.
Department of Geriatrics, Xuanwu Hospital, Capital Medical University, China National Clinical Research Center for Geriatric Medicine, Beijing 100053, China.
J Clin Neurosci. 2020 Nov;81:43-46. doi: 10.1016/j.jocn.2020.09.018. Epub 2020 Sep 25.
China has the largest number of individuals with dementia worldwide. Alzheimer's disease (AD) is a growing global health issue that seriously threatens human health and quality of life and imposes a significant burden on families and society. To date, no treatment exists that can delay AD progression. This review describes the current understanding of AD in China, including its prevalence, cost burden, diagnosis, and treatment, and summarizes the major advances in AD in China, including government strategies and research. Such findings highlight the need for a brain health action plan to prevent and control AD and to reduce its increasing prevalence and dementia-related costs in China.
中国是全球拥有痴呆症患者人数最多的国家。阿尔茨海默病(AD)是一个日益严重的全球健康问题,严重威胁人类健康和生活质量,给家庭和社会带来沉重负担。迄今为止,尚无任何治疗方法可以延缓 AD 的进展。本综述描述了中国对 AD 的现有认识,包括其患病率、经济负担、诊断和治疗,并总结了中国 AD 研究的主要进展,包括政府策略。这些发现强调需要制定一个大脑健康行动计划,以预防和控制 AD,并降低其在中国的患病率和与痴呆症相关的成本不断上升。